ClinicalTrials.gg
BiologicalDrug

Tralokinumab clinical trials

Also written CAT-354.

studies test it
32
open now
2
in phase 3
14
first study started
2006

How each study uses tralokinumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tralokinumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Dec 2021 · ADBRY · BLA 761180 (FDA, Drugs@FDA)
European Union
17 Jun 2021 · Adtralza · EMEA/H/C/005255 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tralokinumab
26
Tralokinumab 300 mg
2
CAT-354 5 mg/kg
2

Development codes

CAT-354
4

Studies by the year they started

32 studies that test it; most in 2018 (6)

Studies that test tralokinumab, by start year
YearStudies
20061
20082
20091
20101
20111
20123
20143
20152
20162
20172
20186
20202
20222
20232
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
10
Phase 3
14
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 28 · Other 4

LEO Pharma (13) · MedImmune LLC (9) · AstraZeneca (6) · Prof. Dr. Stephan Weidinger (1) · Emma Guttman (1) · University of California, San Francisco (1) · Psoriasis Treatment Center of Central New Jersey (1)

Often tested with

Tested in the same studies.

Triamcinolone (1) · Fluorouracil (1) · Calcipotriene (1) · Tapinarof (1) · Crisaborole (1) · Tacrolimus (1) · Adalimumab (1) · Etanercept (1)

Studies

Open first, then newest update. How each study uses tralokinumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 32

See all 32 studies that test tralokinumab →

Codes

What other systems call tralokinumab · ClinicalTrials.gg INT006111

  • MeSH (NLM) C574065tralokinumabOne source NLM
  • UNII (FDA) GK1LYB375ATRALOKINUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 2589225One source FDA
  • Wikidata Q7833105TralokinumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152710TralokinumabOne source FDA
  • DrugBank DB12169One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.